美国 · 平台与数据 · MarketBeat
BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company
Wells Fargo & Company decreased their price objective on BioNTech from $140.00 to $125.00 and set an "overweight" rating for the company in a report on Wednesday.
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)
